(Q37930135)

25 August 2017

1 reference

title

The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors (English)

1 reference

non-small-cell lung carcinoma

25 August 2017

1 reference

1 reference

Giorgio V Scagliotti

1

1 reference

25 August 2017

Silvia Novello

series ordinal

2

1 reference

25 August 2017

publication date

9 September 2011

1 reference

25 August 2017

published in

Cancer Treatment Reviews

1 reference

25 August 2017

volume

38

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

292-302

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

25 August 2017

cites work

Cancer statistics, 2009

1 reference

28 May 2022

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1200/JCO.2008.19.9331

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

1 reference

https://opencitations.net/index/api/v1/citations/10.1038/SJ.BJC.6605972

COCI

reference URL

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

9 February 2024

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-10-0089

Identifiers

DOI

10.1016/J.CTRV.2011.07.008

1 reference

25 August 2017

1 reference